Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PDCD5 and caspase-3 expression in advanced non-small cell lung cancer and sensitivity to platinum chemotherapy
ChiCTR-ONC-13003633Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Shihezi University
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cisplatin in non-small cell lung cancer (NSCLC), sponsored by The First Affiliated Hospital of Shihezi University. Primary endpoint: Protein content. Started Oct 2013; status: completed.
02
Drugs
cisplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ChiCTR-ONC-13003633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-13003633.